SCHEMBL2015686

SCHEMBL2015686

Cc1nn2cc(C(=O)N(C)C(CCNC(=O)c3cccn3C)Cc3ccccc3)nc2s1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.55
HCRTR2 O43614 2/20 0.55
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
PADI4 Q9UM07 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
POLB P06746 1/20 0.34
PKM P14618 1/20 0.34
HPGD P15428 1/20 0.34
HDAC6 Q9UBN7 3/20 0.34
OPRM1 P35372 1/20 0.34
TP53 P04637 1/20 0.33
ALOX15 P16050 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2013002 0.87 HCRTR1 (0.57) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2018124 0.85 HCRTR1 (0.55) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2013001 0.85 HCRTR1 (0.56) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2017397 0.84 HCRTR1 (0.57) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2014124 0.84 HCRTR1 (0.59) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2010539 0.82 HCRTR1 (0.63) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2014309 0.82 HCRTR1 (0.57) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2014229 0.82 HCRTR1 (0.58) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2013183 0.81 HCRTR1 (0.61) HCRTR1HCRTR2NPC1RAB9AHRH3
SCHEMBL2013416 0.80 HCRTR1 (0.60) HCRTR1HCRTR2NPC1RAB9APADI4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed